A First-Time CEO, A First-Time IPO, And A Pandemic
Source: Life Science Leader
In this executive virtual roundtable (EVR) section, Marcio Souza, CEO of Praxis Precision Medicines, a clinical stage biopharma, shares thoughts and experiences from taking his first company public virtually via an Oct. 2020 IPO. Adding to the conversation are David Perry, cofounder and chairman of Better Therapeutics, and Tom Frohlich, CBO, Chinook Therapeutics.
This website uses cookies to ensure you get the best experience on our website. Learn more